Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKS-452 booster in healthy volunteers previously vaccinated against COVID-19
NCT05124483Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
A Phase 2 trial of AKS-452 in coronavirus disease 2019 (COVID-19), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
AKS-452
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05124483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124483.